Sign in
Baseline Characteristics of Patients Who Did or Did Not Maintain 12-Week and 16-Week Aflibercept 8 mg Dosing Intervals in the Phase 2/3 PHOTON Trial
Eric W Schneider, MD
Annual Meeting Talks
2023
Intraoperative OCT: Are we ready for the future?
Justis P. Ehlers, MD, FASRS
Updates from the Field
2017
The Impact of Image Processing Algorithms on Quantitative Optical Coherence Tomography Angiography Metrics in Diabetic Retinopathy
Jay C Wang, MD
2021
Category: Imaging